Older adult patients use more aminosalicylate monotherapy compared with younger patients with inflammatory bowel disease: TARGET-IBD
Journal of Clinical Gastroenterology Jun 22, 2021
Barnes EL, Hanson JS, Regueiro MD, et al. - Researchers conducted the study for describing medication utilization patterns in older inflammatory bowel disease (IBD) patients. Data were obtained from the 34 sites in TARGET-IBD, a multicenter, observational cohort. Pairwise comparisons were used to examine therapy use, and multivariable logistic regression models were used to assess the odds of IBD-specific therapy use among patients over the age of 65. Participants in the study were 2,980 patients with IBD. When compared with younger age groups, older IBD patients use much more aminosalicylate monotherapy and less anti-tumor necrosis factor monotherapy. Given the United States' aging population, these utilization patterns may have long-term implications for disease control.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries